CRP Coronary Disease Test Value Challenged By Icelandic Study – NEJM
This article was originally published in The Gray Sheet
Executive Summary
C-reactive protein diagnostics offered little diagnostic benefit for coronary disease detection in a large prospective Icelandic study published in the April 1 New England Journal of Medicine.
You may also be interested in...
NEJM Study Deems CRP Significant, Compared With Other Cardiac Markers
A recent New England Journal of Medicine study identifying C-reactive protein as a significant marker of coronary heart disease risk may prove to be a boon for CRP diagnostic manufacturers
NEJM Study Deems CRP Significant, Compared With Other Cardiac Markers
A recent New England Journal of Medicine study identifying C-reactive protein as a significant marker of coronary heart disease risk may prove to be a boon for CRP diagnostic manufacturers
Physician Office Labs At Cholestech’s Fingertips: CRP, Waived Tests In Reach
Cholestech will conduct clinical studies to support Medicare reimbursement for Endo-Pat 2000, a device that measures vascular endothelial dysfunction, an early-stage marker of atherosclerosis